These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 14991891

  • 1. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
    Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, Braud AC, Puig B, Geneix J, Hassoun J, Birnbaum D, Jacquemier J, Viens P.
    J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 3. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
    Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.
    Mod Pathol; 2002 Aug 12; 15(8):853-61. PubMed ID: 12181271
    [Abstract] [Full Text] [Related]

  • 4. The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma.
    van der Vegt B, de Roos MA, Peterse JL, Patriarca C, Hilkens J, de Bock GH, Wesseling J.
    Histopathology; 2007 Sep 12; 51(3):322-35. PubMed ID: 17645748
    [Abstract] [Full Text] [Related]

  • 5. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.
    J Pathol; 2006 Mar 12; 208(4):495-506. PubMed ID: 16429394
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.
    J Natl Cancer Inst; 2005 Sep 07; 97(17):1254-61. PubMed ID: 16145046
    [Abstract] [Full Text] [Related]

  • 7. Persistent E-cadherin expression in inflammatory breast cancer.
    Kleer CG, van Golen KL, Braun T, Merajver SD.
    Mod Pathol; 2001 May 07; 14(5):458-64. PubMed ID: 11353057
    [Abstract] [Full Text] [Related]

  • 8. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.
    Am J Surg Pathol; 2008 Apr 07; 32(4):544-52. PubMed ID: 18300793
    [Abstract] [Full Text] [Related]

  • 9. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Apr 07; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory breast cancers in Tunisia and France show similar immunophenotypes.
    Charafe-Jauffret E, Mrad K, Intidhar Labidi S, Ben Hamida A, Ben Romdhane K, Ben Abdallah M, Ginestier C, Esterni B, Birnbaum D, Ben Ayed F, Xerri L, Viens P, Mezlini A, Jacquemier J.
    Breast; 2007 Aug 07; 16(4):352-8. PubMed ID: 17360185
    [Abstract] [Full Text] [Related]

  • 11. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E, Paszko Z, Mazur S.
    Neoplasma; 2005 Aug 07; 52(1):10-7. PubMed ID: 15739020
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of osteopontin in patients with triple-negative breast cancer.
    Wang X, Chao L, Ma G, Chen L, Tian B, Zang Y, Sun J.
    Eur J Clin Invest; 2008 Jun 07; 38(6):438-46. PubMed ID: 18452545
    [Abstract] [Full Text] [Related]

  • 13. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis].
    Meng J, Lang RG, Fan Y, Fu L.
    Zhonghua Zhong Liu Za Zhi; 2007 Apr 07; 29(4):284-8. PubMed ID: 17760256
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
    Rudolph P, Alm P, Olsson H, Heidebrecht HJ, Fernö M, Baldetorp B, Parwaresch R.
    Hum Pathol; 2001 Mar 07; 32(3):311-9. PubMed ID: 11274641
    [Abstract] [Full Text] [Related]

  • 17. Male breast cancer: pathological and immunohistochemical features.
    Willsher PC, Leach IH, Ellis IO, Bell JA, Elston CW, Bourke JB, Blamey RW, Robertson JF.
    Anticancer Res; 1997 Mar 07; 17(3C):2335-8. PubMed ID: 9245247
    [Abstract] [Full Text] [Related]

  • 18. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
    Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kücücük S, Aslay I, Aydiner A, Topuz E.
    Cancer Invest; 2008 Aug 07; 26(7):671-9. PubMed ID: 18608215
    [Abstract] [Full Text] [Related]

  • 19. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH, Xu BH, Zhang P, Li Q, Zhao LM, Sun Y.
    Zhonghua Zhong Liu Za Zhi; 2007 Feb 07; 29(2):137-40. PubMed ID: 17645853
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.